节点文献

MDR1基因与ER及PR在乳腺癌中的表达

Expressions Of MDR And ER/PR In Breast Carcinomas

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 陈宏颖徐朝斌叶彼德肖坚

【Author】 Chen Hongying; et al (Department of Pathology of theFirst Hospital of Sanming )

【机构】 福建省三明市第一医院!365000

【摘要】 目的:检测乳腺癌组织中多药耐药基因的表达并探讨其与ER,PR以及预后的关系。方法:采用S-P免疫织化方法,对120倒乳腺癌组织进行P糖蛋白(PgP),ER/PR表达的检测。结果:乳腺癌组织中P糖蛋白阳性表达为33.3%,ER阳性表达51.7%,PR阳性表达37.5%。P糖蛋白与乳腺癌组织类型及ER/PR天关,PgP,ER/PR阳性表达均与乳腺病预后有关(P<0.01)。结论:PgP,EE/PR三个指标估计乳腺癌预后比单一指标为好。

【Abstract】 Objective: To detect expression of MDR in breast carcinoma and to probe relation with ER/PR and prognosis. Methods: Expressions of PgP and ER/pR in 120 cases of breast carcinomas were detected byS- P Immunohistochemistry. Results: The positive rates of PgP, ER and PR were 33. 3 %, 51. 7 % and 37.5 % respectively. It was found that there was a correlation betwecn the expression of PgP and ER/PR and theprognosis(P < 0. 01 ), but there was no difference between their expression and Histopathilogical type. Conclusions: The results suggested that three indexes are better than the single of them to evaluate the prognosis of patients with breast cancer.

  • 【文献出处】 齐齐哈尔医学院学报 ,Journal of Qiqihar Medical , 编辑部邮箱 ,1999年03期
  • 【分类号】R737.9
  • 【下载频次】17
节点文献中: 

本文链接的文献网络图示:

本文的引文网络